cytarabine and amidox
cytarabine has been researched along with amidox in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bauer, W; Elford, HL; Fritzer-Szekeres, M; Höchtl, T; Horvath, Z; Karl, D; Saiko, P; Szekeres, T | 1 |
| Bauer, W; Fritzer-Szekeres, M; Höchtl, T; Horvath, Z; Karl, D; Saiko, P; Szekeres, T | 1 |
Other Studies
2 other study(ies) available for cytarabine and amidox
| Article | Year |
|---|---|
Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Cell Division; Colony-Forming Units Assay; Cytarabine; Deoxyribonucleotides; Growth Inhibitors; HL-60 Cells; Humans; Oximes; Ribonucleotide Reductases | 2004 |
Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
Topics: Agar; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Cytarabine; Deoxycytosine Nucleotides; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Inhibitory Concentration 50; Oximes; Ribonucleotide Reductases; Time Factors | 2004 |